FFF Enterprises Inc.
FFF Enterprises Inc. and RightNow Inventory™ Become Vital Members of the Artesunate for Injection Distribution Network
08 mars 2023 13h34 HE | FFF Enterprises.com
Temecula, Calif., March 08, 2023 (GLOBE NEWSWIRE) -- FFF Enterprises Inc., the nation’s most trusted specialty drug distributor, today announced that it has partnered with Amivas (US), LLC to stock...
Picture1.png
Ocean Biomedical to Ring The Nasdaq Stock Market Opening Bell
16 févr. 2023 08h01 HE | Ocean Biomedical, Inc.
Ocean Biomedical commenced trading on Nasdaq under ticker symbol "OCEA" on February 15 Providence, RI and New York, NY, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical (“the Company”),...
Logo.png
Malaria Pipeline Clinical Trials Featuring 35+ companies| DelveInsight
04 janv. 2023 13h00 HE | DelveInsight Business Research LLP
New York, USA, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Malaria Pipeline Clinical Trials Featuring 35+ companies| DelveInsight Malaria is one of the most widespread life-threatening diseases, commonly...
BioNTech Initiates P
BioNTech Initiates Phase 1 Clinical Trial for Malaria Vaccine Program BNT165
23 déc. 2022 03h00 HE | BioNTech SE
BioNTech aims to develop the first mRNA-based vaccine for Malaria prevention based on a novel multi-antigen vaccine approachFirst evaluated candidate BNT165b1 expresses certain parts of the...
BioNTech beginnt kli
BioNTech beginnt klinische Phase-1-Studie mit Malaria-Impfstoffprogramm BNT165
23 déc. 2022 03h00 HE | BioNTech SE
BioNTechs Ziel ist es, den ersten mRNA-basierten Impfstoff zur Prävention von Malaria zu entwickeln, der auf einem neuartigen Multi-Antigen-Impfstoffansatz basiert.Der erste in der Klinik untersuchte...
BioNTech Starts Cons
BioNTech Starts Construction of First mRNA Vaccine Manufacturing Facility in Africa
23 juin 2022 06h00 HE | BioNTech SE
Breaking of Ground for BioNTech’s initial African modular mRNA manufacturing facility in Kigali, Rwanda; delivery of first container modules planned for end of 2022On invitation by H.E. President Paul...
BioNTech beginnt Bau
BioNTech beginnt Bau der ersten Produktionsstätte für mRNA-basierte Impfstoffe in Afrika
23 juin 2022 06h00 HE | BioNTech SE
Spatenstich in Kigali, Ruanda, für BioNTechs erste modulare mRNA-Produktionsstätte in Afrika; Lieferung der ersten Containermodule für Ende 2022 geplantAuf Einladung von Paul Kagame, Präsident der...
NOVARTIS logo.jpg
Novartis renews commitment to neglected tropical disease and malaria elimination, investing USD 250 million over five years to research and develop new treatments
22 juin 2022 20h01 HE | Novartis Pharma AG
Novartis endorses the Kigali Declaration on neglected tropical diseases, pledging USD 250 million to advance R&D of new treatments against NTDs and malaria over five yearsCommitment includes USD...
Featured Image for Experimental Biology and Medicine
New Study Identifies Potential Immunotherapy Target for Malaria
09 mai 2022 10h00 HE | Experimental Biology and Medicine
WASHINGTON, May 09, 2022 (GLOBE NEWSWIRE) -- A recently published article in Experimental Biology and Medicine (Volume 247, Issue 8, April, 2022) identifies a new target for malaria treatment. The...
22157.jpg
Insights on the Malaria Diagnostics Global Market to 2026 - by Technology, End-use and Region
25 mars 2022 08h58 HE | Research and Markets
Dublin, March 25, 2022 (GLOBE NEWSWIRE) -- The "Malaria Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...